View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.
View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.
CMS will host an informational webinar April 16 to provide an overview of CMS Interoperability Standards & Prior Authorization for Drugs proposed rule.